http://www.xconomy.com/san-diego/2009/05/14/regulus-hits-gsk-milestone/ Business + Technology in the Exponential Economy Sun, 22 Nov 2009 19:43:29 -0600 http://wordpress.org/?v=2.8.6 hourly 1 http://www.xconomy.com/san-diego/2009/05/14/regulus-hits-gsk-milestone/comment-page-1/#comment-58870 Regulus Hits GSK Milestone | Xconomy « Biotech Beach Bum Tue, 19 May 2009 14:53:23 +0000 http://www.xconomy.com/?p=24795#comment-58870 [...] Regulus Hits GSK Milestone | Xconomy Regulus’s new microRNA blocker technology (aka anti-MIR) hits its first milestone for marketing/funding partner GSK. This promising approach delivers small pieces of RNA into cells to block transcription and thereby slow gene expression.  http://www.xconomy.com/san-diego/2009/05/14/regulus-hits-gsk-milestone/ [...] [...] Regulus Hits GSK Milestone | Xconomy Regulus’s new microRNA blocker technology (aka anti-MIR) hits its first milestone for marketing/funding partner GSK. This promising approach delivers small pieces of RNA into cells to block transcription and thereby slow gene expression.  http://www.xconomy.com/san-diego/2009/05/14/regulus-hits-gsk-milestone/ [...]

]]>